Sign up
Healthed-White-on-Blue
Woo, Henry

Prof Henry Woo

Urological Surgeon; Professor of Surgery and Discipline of Surgery, Head, Sydney Adventist Hospital Clinical School, University of Sydney; Director, Uro-Oncology, Professor, Robotic Cancer Surgery, Chris O’Brien Lifehouse
Prof Henry Woo is a urological surgeon sub-specialising in Prostate Surgery. He is Professor of Surgery and Discipline of Surgery Head at the Sydney Adventist Hospital Clinical School of the University of Sydney. He is also Director of Uro-Oncology and Professor of Robotic Cancer Surgery at the Chris O’Brien Lifehouse.

More from this expert

Man,In,Consultation,,Dialogue
Podcasts iconPodcasts

The role of GP in post prostate cancer care

Up-to-date and evidence-based advice to post radical prostatectomy patients- managing their expectations, effective therapies and realistic time-frames for recovery, latest information on androgen deprivation therapy.

Man,In,Consultation,,Dialogue

The role of GP in post prostate cancer care

Up-to-date and evidence-based advice to post radical prostatectomy patients- managing their expectations, effective therapies and realistic time-frames for recovery, latest information on androgen deprivation therapy.

By Prof Henry Woo
Podcasts iconPodcasts
Dr Henry Woo_Image0

Degarelix injections for the treatment of prostate cancer

In this Product Explainer Urologist Prof Henry Woo explains the role of degarelix injections as part of the management of locally advanced or metastatic prostate cancer (3 mins).

By Prof Henry Woo
Videos iconVideos
mockup-graphics-Ox_u9F-UqPI-unsplash-scaled

Prostate cancer: Common GP questions

Urological surgeon Professor Henry Woo answers common questions that GPs have about prostatectomy

By Prof Henry Woo
Clinical Articles iconClinical Articles

Discover

Healthed

CPD platform

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Register for webcast